Drug Enforcement D-1171-2023

Failed dissolution specifications - results obtained were below spec average.

Status

Terminated

Classification

Class II

Report Date

September 27, 2023

Termination Date

August 19, 2024

Product Information

Product description
Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93
Product quantity
9,890 bottles
Reason for recall
Failed dissolution specifications - results obtained were below spec average.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
USA nationwide

Location & Firm

Recalling firm
Aurobindo Pharma USA Inc.
Address
279 Princeton Hightstown Rd

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-1171-2023
Event ID
92948
Recall initiation date
August 2, 2023
Center classification date
September 18, 2023
Code info
Lot #: 3112444, Exp 8/2023
More code info